Healthcare -
Biotechnology - NASDAQ - US
$ 12.05
-14.9 %
$ 178 M
Market Cap
-0.54
P/E
LYEL - CASH FROM FINANCING ACTIVITIES
Cash from Financing Activities LYEL - Lyell Immunopharma, Inc.
1.33 M
LAST VALUE
-64.69%
2 YEAR CAGR
-67.24%
5 YEAR CAGR
0.00%
10 YEAR CAGR